Table 2 Proteins related to clinical characteristics among suicide completers.
From: Proteomic profiling of postmortem prefrontal cortex tissue of suicide completers
Comparative groups | Psychiatric disorders | Medications | Alcohol intake | |||
|---|---|---|---|---|---|---|
Psychiatric disorder vs. No disorder (11: 12) | Schizophrenia vs. No disorder (7: 12) | MDD vs. No disorder (4: 12) | Psychotropics vs. No medication (10: 13) | Antipsychotics vs. No medication (6: 13) | Alcohol intake vs. No-alcohol (6: 17) | |
Number of DEPs (Student’s t-test P < 0.05 & FC > 1.2) | 4 | 13 | 8 | 5 | 12 | 34 |
Gene names | NIPSNAP3B | EPB41L1 | FGG | BCAS1 | CEP170B | GFAP |
| Â | GSTT1a | NIPSNAP3B | NIPSNAP3B | NIPSNAP3B | EPB41L1 | CACNA1E |
| Â | TSPAN8 | CHI3L1 | ACBD3 | NQO1 | EPB41L1 | SLC1A3 |
| Â | NQO1 | STBD1 | DCHS1 | GPNMB | BCAS1 | COL6A1 |
| Â | Â | EMILIN2 | GSTT2 | APOA2 | CFAP36 | ANK3 |
| Â | Â | SLC14A1 | LRP2 | Â | COL4A1a | RASA4 |
| Â | Â | MORF4L2 | ABCC10 | Â | CD82a | COL6A3 |
| Â | Â | NELFE | CHRNA4 | Â | STBD1 | RPS4Y1a |
| Â | Â | TSPAN8 | Â | Â | MORF4L2 | SLC7A11 |
| Â | Â | CDKN2AIP | Â | Â | NELFE | CD44 |
| Â | Â | NQO1 | Â | Â | TTR | MICALL2 |
| Â | Â | ABRACLa | Â | Â | GPNMB | FAM92A1 |
| Â | Â | UBE2D3a | Â | Â | Â | S100A10a |
| Â | Â | Â | Â | Â | Â | TSPAN15 |
| Â | Â | Â | Â | Â | Â | MRGPRFa |
| Â | Â | Â | Â | Â | Â | MAN2A1 |
| Â | Â | Â | Â | Â | Â | IGHG1 |
| Â | Â | Â | Â | Â | Â | IGHG1 |
| Â | Â | Â | Â | Â | Â | SERPINA1 |
| Â | Â | Â | Â | Â | Â | IGHA1 |
| Â | Â | Â | Â | Â | Â | IGKV3-11 |
| Â | Â | Â | Â | Â | Â | IGHM |
| Â | Â | Â | Â | Â | Â | HPX |
| Â | Â | Â | Â | Â | Â | IGLC2 |
| Â | Â | Â | Â | Â | Â | IGLL5 |
| Â | Â | Â | Â | Â | Â | IGHM |
| Â | Â | Â | Â | Â | Â | IGKV3-20 |
| Â | Â | Â | Â | Â | Â | AHSG |
| Â | Â | Â | Â | Â | Â | IGKV2D-28 |
| Â | Â | Â | Â | Â | Â | IGKV1D-33 |
| Â | Â | Â | Â | Â | Â | IGKV2-30 |
| Â | Â | Â | Â | Â | Â | IGLV3-21 |
| Â | Â | Â | Â | Â | Â | SYT6 |
| Â | Â | Â | Â | Â | Â | CD5L |